{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:00:37Z","timestamp":1783472437708,"version":"3.55.0"},"reference-count":28,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Objective: Vaccines are effective in controlling and eradicating infectious diseases. However, adverse events following immunization (AEFI) can occur in susceptible individuals. The objective of this study was to analyze the Brazilian AEFI database and compare eight vaccines in order to profile risks of AEFIs related to the mandated pediatric schedule of immunization, considering the age and sex of the child, type of vaccine, and reported adverse events. Methods: We analyzed the Brazilian AEFI database integrating reports between 2005 and 2010 for children less than 10-years old immunized with eight mandated vaccines: diphtheria, pertussis, tetanus, Haemophilus influenzae type b (TETRA); diphtheria, tetanus, and pertussis (DTP); Bacillus Calmette\u2013Guerin (BCG); oral poliovirus vaccine (OPV); measles, mumps, and rubella (MMR); oral rotavirus vaccine (ORV); hepatitis B (HB); and yellow fever (YF). We compared the children\u2019s age regarding types of AEFI, evaluated AEFI factors associated with the chance of hospitalization of the child, and estimated the chance of notification of an AEFI as a function of the type of vaccine. In total, 47,105 AEFIs were observed for the mandated vaccines. Results: The highest AEFI rate was for the TETRA vaccine and the lowest was for the OPV vaccine, with 60.1 and 2.3 events per 100,000 inoculations, respectively. The TETRA vaccine showed the highest rate of hypotonic hyporesponsive episode, followed by convulsion and fever. The MMR and YF vaccines were associated with generalized rash. BCG was associated with enlarged lymph glands but showed the largest negative (protective) association with hyporesponsive events and seizures. Compared with children aged 5\u20139-years old, young children (&lt;1 year) showed significantly higher odds of hospitalization. Conclusions: The Brazilian AEFI registry is useful to compare the magnitude and certain characteristics of adverse events associated with mandated pediatric vaccines.<\/jats:p>","DOI":"10.3390\/ijerph15061149","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T08:52:03Z","timestamp":1528102323000},"page":"1149","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adverse Events Following Immunization in Brazil: Age of Child and Vaccine-Associated Risk Analysis Using Logistic Regression"],"prefix":"10.3390","volume":"15","author":[{"given":"S\u00edlvia R.C.","family":"Lopes","sequence":"first","affiliation":[{"name":"Institute of Mathematics, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre RS 91509-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o L.R.","family":"Perin","sequence":"additional","affiliation":[{"name":"Management and Technical Support, StatSoft South America, Porto Alegre RS 90040-190 Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiane S.","family":"Prass","sequence":"additional","affiliation":[{"name":"Statistics Department, Federal University of Santa Maria (UFSM), Santa Maria RS 97105-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Maria D.","family":"Carvalho","sequence":"additional","affiliation":[{"name":"National Immunization Program\/SVS\/MS, Bras\u00edlia 70058-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio C.","family":"Lessa","sequence":"additional","affiliation":[{"name":"National Research Council (CNPq), COAGR\/CGAPB, Bras\u00edlia 71605-001, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3941-1638","authenticated-orcid":false,"given":"Jos\u00e9 G.","family":"D\u00f3rea","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, University of Bras\u00edlia, Bras\u00edlia 70919-970, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"ref_1","first-page":"49","article-title":"Centersfor Disease Control and Prevention (CDC). Vaccine-preventable diseases, immunizations, and MMWR\u20141961\u20132011","volume":"60","author":"Hinman","year":"2011","journal-title":"MMWR Surveill. Summ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/INF.0b013e3181a6a511","article-title":"Adversomics: The emerging field of vaccine adverse event immunogenetics","volume":"28","author":"Poland","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1086\/322569","article-title":"Combination vaccines: Postlicensure safety evaluation","volume":"33","author":"Chen","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill. Summ."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.arcped.2005.10.020","article-title":"Pharmacovigilance of vaccines","volume":"13","year":"2006","journal-title":"Arch. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1016\/j.vaccine.2016.10.039","article-title":"Vaccine safety evaluation: Practical aspects in assessing benefits and risks","volume":"34","author":"Bonanni","year":"2016","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1590\/S0034-89102011000100020","article-title":"Surveillance of adverse effects following vaccination and safety of immunization programs","volume":"45","author":"Waldman","year":"2011","journal-title":"Revista de Saude Publica"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.vaccine.2010.02.059","article-title":"Surveillance for adverse events after DTwP\/Hib vaccination in Brazil: Sensitivity and factors associated with reporting","volume":"28","author":"Monteiro","year":"2010","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"B54","DOI":"10.1016\/j.vaccine.2012.11.084","article-title":"Vaccine research, development, and innovation in Brazil: A translational science perspective","volume":"31","author":"Homma","year":"2013","journal-title":"Vaccine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(11)60202-X","article-title":"Successes and failures in the control of infectious diseases in Brazil: Social and environmental context, policies, interventions, and research needs","volume":"377","author":"Barreto","year":"2011","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Agresti, A. (2007). An Introduction to Categorical Data Analysis, Wiley.","DOI":"10.1002\/0470114754"},{"key":"ref_12","unstructured":"Daniel, W.W. (1978). Applied Nonparametric Statistics, Houghton Mifflin Co."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hosmer, D.W., and Lemeshow, S. (2000). Applied Logistic Regression, Wiley.","DOI":"10.1002\/0471722146"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kleinbaum, D.G., and Klein, M. (2010). Logistic Regression: A Self-Learning Text, Springer. [3rd ed.].","DOI":"10.1007\/978-1-4419-1742-3"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1651-2227.2009.01345.x","article-title":"Breastfeeding is an essential complement to vaccination","volume":"98","year":"2009","journal-title":"Acta Paediatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1055\/s-0032-1316442","article-title":"Breast-feeding and responses to infant vaccines: Constitutional and environmental factors","volume":"29","year":"2012","journal-title":"Am. J. Perinatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.puhe.2015.11.010","article-title":"Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system","volume":"135","year":"2016","journal-title":"Public Health"},{"key":"ref_18","first-page":"e237","article-title":"Vaccination and neurological disorders","volume":"7","author":"Gkampeta","year":"2015","journal-title":"J. Pediatr. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1016\/j.vaccine.2011.04.055","article-title":"Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review","volume":"29","author":"Thomas","year":"2011","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1016\/j.vaccine.2014.05.003","article-title":"Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil","volume":"32","author":"Carvalho","year":"2014","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1517\/14740338.2016.1167869","article-title":"Adverse events following immunization: Real causality and myths","volume":"15","author":"Principi","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2004.09.007","article-title":"Mechanistic actions of the risks and adverse events associated with vaccine administration","volume":"114","author":"Moylett","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.envres.2016.10.028","article-title":"Low-dose Thimerosal in pediatric vaccines: Adverse effects in perspective","volume":"152","year":"2017","journal-title":"Environ. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/0960327112440111","article-title":"Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990\u20132010","volume":"31","author":"Goldman","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/14760584.2015.1038249","article-title":"Adversomics: A new paradigm for vaccine safety and design","volume":"14","author":"Whitaker","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the VaccineAdverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"ref_28","first-page":"482","article-title":"Judicializa\u00e7\u00e3o dos eventos adversos p\u00f3s-vacinais","volume":"25","author":"Campos","year":"2017","journal-title":"Rev. Bioet."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/15\/6\/1149\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:06:54Z","timestamp":1760195214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/15\/6\/1149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["ijerph15061149"],"URL":"https:\/\/doi.org\/10.3390\/ijerph15061149","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}